Clearstead Advisors, LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Clearstead Advisors, LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1151300.0%0.00%
Q3 2022$01300.0%0.00%
Q2 2022$01300.0%0.00%
Q1 2022$0
-100.0%
1300.0%0.00%
Q4 2021$1,0000.0%1300.0%0.00%
Q3 2021$1,0000.0%1300.0%0.00%
Q2 2021$1,0000.0%1300.0%0.00%
Q1 2021$1,0000.0%1300.0%0.00%
Q4 2020$1,0001300.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders